PARTNER CONTENT PROVIDED BY ALZHEON, INC.

Preserving Future Memories

Alzheon is poised to introduce the first oral treatment that can slow or stop Alzheimer's disease.

The Science Behind the Drug That May Stop Alzheimer’s Disease in Its Tracks

Video Shows a Novel Approach to Treating Alzheimer’s Disease

In this video we uncover ALZ-801 (valiltramiprosate), the first potential disease-modifying oral treatment for patients with Alzheimer’s disease, and take a look into its novel mode of action. This groundbreaking drug works by preventing formation of neurotoxic amyloid oligomers.

Click here for more information about Alzheon, Inc. and ALZ-801.